Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

Potential of Houseflies To Contaminate Ready-to-Eat Food with Antibiotic-Resistant Enterococci

(2016) LILIA MACOVEI et al.   JOURNAL OF FOOD PROTECTION

Transferable Plasmid-Mediated Resistance to Linezolid Due tocfrin a Human Clinical Isolate of Enterococcus faecalis

(2012) Lorena Diaz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes

(2012) Xiang Qin et al.   BMC MICROBIOLOGY

Unmet Needs and Prospects for Oritavancin in the Management of Vancomycin-Resistant Enterococcal Infections

(2012) Cesar A. Arias et al.   CLINICAL INFECTIOUS DISEASES

Colonization with Vancomycin-Intermediate Staphylococcus aureus Strains Containing the vanA Resistance Gene in a Tertiary-Care Center in North India

(2012) T. Banerjee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Genetic Characterization of a Vancomycin-Resistant Staphylococcus aureus Isolate from the Respiratory Tract of a Patient in a University Hospital in Northeastern Iran

(2012) A. Azimian et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Galleria mellonella as aModel for Studying Enterococcus faecium Host Persistence

(2012) François Lebreton et al.   JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY

The rise of the Enterococcus: beyond vancomycin resistance

(2012) Cesar A. Arias et al.   NATURE REVIEWS MICROBIOLOGY

AsrR Is an Oxidative Stress Sensing Regulator Modulating Enterococcus faecium Opportunistic Traits, Antimicrobial Resistance, and Pathogenicity

(2012) François Lebreton et al.   PLoS Pathogens

d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium

(2011) François Lebreton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Basis for Daptomycin Resistance in Enterococci

(2011) Kelli L. Palmer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

(2011) George Sakoulas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17

(2011) P. Ruiz-Garbajosa et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures

(2011) P. J. Johnsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08

(2011) N. Bourdon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk of Highly Resistant Bacteria Importation from Repatriates and Travelers Hospitalized in Foreign Countries: About the French Recommendations to Limit Their Spread

(2011) Didier Lepelletier et al.   JOURNAL OF TRAVEL MEDICINE

In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008

(2011) R. Bérenger et al.   MEDECINE ET MALADIES INFECTIEUSES

Antibiotic resistance is ancient

(2011) Vanessa M. D’Costa et al.   NATURE

Genetic Basis for In Vivo Daptomycin Resistance in Enterococci

(2011) Cesar A. Arias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureus

(2010) W. Zhu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium

(2010) X. Xu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Global Spread of the hylEfm Colonization-Virulence Gene in Megaplasmids of the Enterococcus faecium CC17 Polyclonal Subcluster

(2010) A. R. Freitas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island

(2010) Willem van Schaik et al.   BMC GENOMICS

Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results

(2010) Shannon D. Putnam et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay

(2010) Nancy Bourdon et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial-Resistant Enterococci in Animals and Meat: A Human Health Hazard?

(2010) Anette M. Hammerum et al.   Foodborne Pathogens and Disease

A potential role for daptomycin in enterococcal infections: what is the evidence?

(2010) R. Canton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains

(2010) A. R. Corvaglia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci

(2010) M.-L. Foucault et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular characterization of antimicrobial resistance in enterococci and Escherichia coli isolates from European wild rabbit (Oryctolagus cuniculus)

(2010) Nuno Silva et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus

(2009) M.-L. Foucault et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transition ofEnterococcus faeciumfrom commensal organism to nosocomial pathogen

(2009) Rob JL Willems et al.   Future Microbiology

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

(2009) John F. Mohr et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

(2009) V. Mave et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Enterococcal Surface Protein Transiently AggravatesEnterococcus faecium–Induced Urinary Tract Infection in Mice

(2009) Masja Leendertse et al.   JOURNAL OF INFECTIOUS DISEASES

Quelles nouveautés en antibiothérapie ?

(2009) V. Cattoir et al.   MEDECINE ET MALADIES INFECTIEUSES

Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL

(2008) D. A. Boyd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006

(2008) D. M. Sievert et al.   CLINICAL INFECTIOUS DISEASES

Presence of vancomycin and ampicillin-resistant Enterococcus faecium of epidemic clonal complex-17 in wastewaters from the south coast of England

(2008) Jonathan L. Caplin et al.   ENVIRONMENTAL MICROBIOLOGY

Prevalence and characterization of Enterococcus spp. isolated from Brazilian foods

(2008) Bruna C. Gomes et al.   FOOD MICROBIOLOGY

Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs

(2008) Isabelle Kempf et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals

(2008) C. H. Lester et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)

(2007) B. Saha et al.   JOURNAL OF MEDICAL MICROBIOLOGY